Structured evidence table for Mastic Gum Gut Health Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Mastic Gum Gut Health Randomized Trial | Additionally, local healthcare providers have improved geographically equitable access to clinical trials for patients [,]. | 2 | Park Jiyeon (2025) | Methodology for Assessing Patient Centricity and Data Integrity in Clinical Trials With Decentralized Elements: A Pilot Trial on Mastic Gum |
| Mastic Gum Gut Health Randomized Trial | Remote data collection poses potential risks to data integrity through various pathways: procedural variability between practitioners [], missing data collection [], and errors associated with digital technologies, such as unstable data transfer [], interoperability challenges across multiple data sources [,], and security vulnerabilities []. | 2 | Park Jiyeon (2025) | Methodology for Assessing Patient Centricity and Data Integrity in Clinical Trials With Decentralized Elements: A Pilot Trial on Mastic Gum |
| Mastic Gum Gut Health Randomized Trial | = − Burden traditional Burden decentralized decentralized traditional We defined patient centricity as a reduction in participants' perceived burden associated with trial‐related procedures. | 2 | Park Jiyeon (2025) | Methodology for Assessing Patient Centricity and Data Integrity in Clinical Trials With Decentralized Elements: A Pilot Trial on Mastic Gum |
| Mastic Gum Gut Health Randomized Trial | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 The growing emphasis on patient centricity has accelerated decentralization of the clinical trials [,,]. | 2 | Park Jiyeon (2025) | Methodology for Assessing Patient Centricity and Data Integrity in Clinical Trials With Decentralized Elements: A Pilot Trial on Mastic Gum |
| Mastic Gum Gut Health Randomized Trial | The escalating global prevalence of antibiotic-resistant Helicobacter pylori strains has undermined conventional eradication therapies, heightening the burden of associated conditions such as gastritis, peptic ulcers and gastric malignancies. | 4 | Fath Tabar A (2026) | Beyond Antibiotics: Alternative Strategies Targeting <i>Helicobacter pylori</i> Resistance. |
| Mastic Gum Gut Health Randomized Trial | Emerging non-antibiotic alternatives, including natural and synthetic compounds, probiotics and vaccine candidates, offer potential solutions to combat these infections effectively. | 4 | Fath Tabar A (2026) | Beyond Antibiotics: Alternative Strategies Targeting <i>Helicobacter pylori</i> Resistance. |
Source documents